Market size in innovation
theory and evidence from the pharmaceutical industry
by Daron Acemoglu
- 0 Ratings
- 0 Want to read
- 0 Currently reading
- 0 Have read
This paper investigates the effect of (potential) market size on entry of new drugs and pharmaceutical innovation. Focusing on exogenous changes driven by U.S. demographic trends, we find that a 1 percent increase in the potential market size for a drug category leads to a 4 to 6 percent increase in the number of new drugs in that category. This response comes from both the entry of generic drugs and new non-generic drugs, and is generally robust to controlling for a variety of non-profit factors, pre-existing trends, and changes in health care coverage. Keywords: Economic Growth, Entry, Innovation, Pharmaceuticals, Profit Incentives. JEL Classifications: O31, O33, L65.
Check nearby libraries
Buy this book
Previews available in: English
Showing 1 featured edition. View all 1 editions?
| Edition | Availability |
|---|---|
1
Market size in innovation: theory and evidence from the pharmaceutical industry
2003, Massachusetts Institute of Technology, Dept. of Economics
in English
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Edition Notes
"September, 2003."
Includes bibliographical references (p. 35-37).
Abstract in HTML and working paper for download in PDF available via World Wide Web at the Social Science Research Network.
Partially funded by the National Science Foundation and the Russell Sage Foundation.
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?
History
- Created April 30, 2011
- 2 revisions
Wikipedia citation
×CloseCopy and paste this code into your Wikipedia page. Need help?
| April 30, 2011 | Edited by ImportBot | Added new cover |
| April 30, 2011 | Created by ImportBot | Imported from Internet Archive item record |